These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15559874)

  • 1. [On metabolic therapeutics G-I-K in surgery of cardiac patients].
    de Micheli A; Medrano GA
    Arch Cardiol Mex; 2004; 74(3):215-9. PubMed ID: 15559874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic support of the ischemic heart during cardiac surgery].
    Luna Ortiz P; Serrano Valdés X; Rojas Pérez E; de Micheli A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S121-36. PubMed ID: 17469340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials.
    Schipke JD; Friebe R; Gams E
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):479-85. PubMed ID: 16481185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial.
    Quinn DW; Pagano D; Bonser RS; Rooney SJ; Graham TR; Wilson IC; Keogh BE; Townend JN; Lewis ME; Nightingale P;
    J Thorac Cardiovasc Surg; 2006 Jan; 131(1):34-42. PubMed ID: 16399292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis.
    Fan Y; Zhang AM; Xiao YB; Weng YG; Hetzer R
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):192-9. PubMed ID: 21075642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic modulation for cardiac protection.
    Weinberg GL; Massad MG
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):135-8. PubMed ID: 17338658
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose, insulin, and the cardiovascular system.
    Broomhead CJ; Colvin MP
    Heart; 2001 May; 85(5):495-6. PubMed ID: 11302992
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucose-insulin-potassium (GIK) in the reduction of acute myocardial ischemia after an aortocoronary bypass intervention].
    Dainese L; Polvani GL; Fumero A; Spirito R; Alamanni F; Agrifoglio M; Parolari A; Biglioli P
    G Ital Cardiol; 1999 May; 29(5):575-9; discussion 580-2. PubMed ID: 10367228
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of glucose-insulin-potassium solution on ketosis following cardiac surgery.
    Moffitt EA; Rosevear JW; Molnar GD; McGoon DC
    Anesth Analg; 1971; 50(2):291-7. PubMed ID: 5102646
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic intervention for the ischemic and post-ischemic heart.
    Svedjeholm R; Håkanson E; Szabó Z
    Wien Klin Wochenschr; 1999 Jul; 111(13):501-11. PubMed ID: 10444803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic therapy in cardiac surgery--"Optimizing the engine's fuel supply and more...".
    Doenst T; Amorim PA
    Scand Cardiovasc J; 2010 Feb; 44(1):4-8. PubMed ID: 20141343
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart.
    Grossman AN; Opie LH; Beshansky JR; Ingwall JS; Rackley CE; Selker HP
    Circulation; 2013 Mar; 127(9):1040-8. PubMed ID: 23459576
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glucose-insulin-potassium (GIK) solution: cardioprotective effects of insulin].
    Rojas Pérez EM; Luna Ortiz P; Serrano Valdez X; Fernández Rivera BJ; de Micheli A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S144-51. PubMed ID: 17469342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic therapy with glucose-insulin-potassium. Historical outline].
    de Micheli A
    Arch Inst Cardiol Mex; 2000; 70(6):609-15. PubMed ID: 11255721
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy with glucose-insulin-potassium reduces the complications in the acute phase of myocardial infarct. Arguments in favor].
    Alegría Ezquerra E; Maceria González A
    Rev Esp Cardiol; 1998 Sep; 51(9):720-6. PubMed ID: 9803797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting.
    Ranasinghe AM; Quinn DW; Pagano D; Edwards N; Faroqui M; Graham TR; Keogh BE; Mascaro J; Riddington DW; Rooney SJ; Townend JN; Wilson IC; Bonser RS
    Circulation; 2006 Jul; 114(1 Suppl):I245-50. PubMed ID: 16820580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
    Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy with insulin in cardiac surgery: controversies and possible solutions.
    Doenst T; Bothe W; Beyersdorf F
    Ann Thorac Surg; 2003 Feb; 75(2):S721-8. PubMed ID: 12607718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is justified the use of GIK solutions in acute myocardial infarct?].
    de Micheli A
    Arch Cardiol Mex; 2008; 78(3):243-6. PubMed ID: 18959010
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
    Apstein CS
    JAMA; 2005 Jun; 293(21):2596-7; author reply 2598. PubMed ID: 15928276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.